Essilor International SA (OTCMKTS:ESLOY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday.
According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “
Essilor International SA (OTCMKTS:ESLOY) traded down 1.64% during trading on Tuesday, hitting $63.73. The stock had a trading volume of 5,998 shares. Essilor International SA has a 52-week low of $57.73 and a 52-week high of $67.99. The company has a 50-day moving average price of $64.57 and a 200-day moving average price of $64.36. The company has a market cap of $27.43 billion, a price-to-earnings ratio of 31.39 and a beta of 0.75.
Essilor International SA Company Profile
Essilor International Compagnie Generale D’Optique SA is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with MarketBeat.com's FREE daily email newsletter.